Key result
Hyperbaric oxygen treatment for carbon monoxide poisoning lacks sufficient evidence for patients with impaired consciousness or cardiovascular instability, who were excluded from a cited trial.
Why the study?
Does hyperbaric oxygen improve outcomes in patients with carbon monoxide poisoning?
Does hyperbaric oxygen improve outcomes in patients with carbon monoxide poisoning?
This letter challenges the recommendation for hyperbaric oxygen in severe carbon monoxide poisoning, citing a lack of robust randomized evidence for patients with cardiovascular instability or impaired consciousness.
Carbon monoxide poisoningSir,The recent review of carbon monoxide poisoning by Balzan et al' provided helpful advice about this sometimes difficult diagnosis.We would, however, hesitate to follow the recommendations made about the treatment of CO poisoning.Their assessment of the benefit of hyperbaric oxygen (HBO) does not appear to be based on the presented evidence and the potential complications of transporting critically ill patients to HBO facilities do not receive the attention they merit.The authors cite one randomised trial assessing HBO in patients who were not pregnant.2The indications they propose for HBO include two (impaired consciousness and cardiovascular instability) that were the exclusion criteria in this trial.Case series are also cited.3'4We do not believe these provide sufficient information to allow clinically useful comparison between different treatments.Their role is to generate rather than to test hypotheses.We conclude with the observation of Thom et al (our italics)2; "Questions that should be addressed include whether treating patients [with hyperbaric oxygen] more than 6 hours after poisoning is effective and whether the benefits outweigh the costs of transportation and treatment."
No takes yet. Share an insight, caveat, or question.
Oscar M.P. Jolobe (1997) conducted a letter in Carbon monoxide poisoning. Hyperbaric oxygen was evaluated. Hyperbaric oxygen treatment for carbon monoxide poisoning lacks sufficient evidence for patients with impaired consciousness or cardiovascular instability, who were excluded from a cited trial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: